October 21, 2015 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/ researchfunding/newsletter/ 2015/Pages/1021.aspx
Feature Articles
Application Missteps—Unfocused Hypothesis or Specific Aims
After covering must-avoids like proposing a Weak Project and Misfiring on Innovation, we now tackle another pitfall to sidestep: lack of focus in your hypothesis and Specific Aims.
Opportunities and Resources
Opportunity to Characterize Mycobacterial-Induced Immunity
Apply for exploratory/developmental research (R21) funds to perform hypothesis-generating research on the immunological responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or progression to active TB in HIV-infected or uninfected people.
In The News
Summary of September Council: Budget, Concepts
The September 21, 2015 advisory Council meeting has come and gone, but you can still catch up on what transpired by reading this article and watching videocasts.
The Office of Extramural Research Welcomes a New Director
NIH has chosen Michael S. Lauer, M.D., to be the new deputy director for extramural research and director of the NIH Office of Extramural Research.
News Briefs
- NIAID Operates Under a Continuing Resolution
- Find News and Resources From CSR
- Participate in National Biosafety Stewardship Month
Advice Corner
Understanding Indirect Costs
Having trouble distinguishing between direct and indirect costs for your federally funded research project? Check out the Office of Extramural Research’s YouTube presentation Indirect Costs 101.
Reader Questions
- Can I request eligibility for the F31 Diversity grant? I am Filipino American, but Filipinos are not identified as a disadvantaged group in the NIH guidelines since they are categorized as Asians, even though Filipinos are greatly underrepresented in STEM fields.
- Can I submit a new grant, modified from an unfunded resubmission (A1), using the exact same title?
New Funding Opportunities
- RFA-AI-15-054, Discovery/
Development of Novel Therapeutics for Eukaryotic Pathogens (R21/R33) - RFA-AI-15-055, B Cell Immunology Program for HIV-1 Vaccine Development (BCIP) (R01)
See other announcements at NIAID Funding Opportunities List.
Send suggestions or comments to deaweb@niaid.nih.gov.


No hay comentarios:
Publicar un comentario